| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:07:52 -0700 |
| HMDB ID |
HMDB00087 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Dimethylamine |
| Description |
Dimethylamine (DMA) is an organic secondary amine. It is a colorless, liquefied and flammable gas with an ammonia and fish-like odor. Dimethylamine is abundantly present in human urine. Main sources of urinary DMA have been reported to include trimethylamine N-oxide, a common food component, and asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthesis. ADMA is excreted in the urine in part unmetabolized and in part after hydrolysis to DMA by dimethylarginine dimethylaminohydrolase (DDAH). Statistically significant increases in urinary DMA have been found in individuals after the consumption of fish and seafoods. The highest values were obtained for individuals that consumed coley, squid and whiting with cod, haddock, sardine, skate and swordfish (PMID: 18282650 ). As a pure chemical substance Dimethylamine is used as dehairing agent in tanning, in dyes, in rubber accelerators, in soaps and cleaning compounds and as an agricultural fungicide. In the body, DMA also undergoes nitrosation under weak acid conditions to give dimethlynitrosamine. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- Dimethylamine
- Dimethylamine anhydrous
- Dimethylamine anhydrous (dot)
- Dimethylamine aqueous solution
- Dimethylamine hydrobromide
- Dimethylamine solution
- N,N-Dimethylamine
- N-Methyl-Methanamine
- N-Methylmethanamine
- N-Methylmethanamine (ACD/Name 4.0)
|
| Chemical Formula |
C2H7N |
| Average Molecular Weight |
45.0837 |
| Monoisotopic Molecular Weight |
45.057849229 |
| IUPAC Name |
dimethylamine |
| Traditional IUPAC Name |
dimethylamine |
| CAS Registry Number |
124-40-3 |
| SMILES |
CNC |
| InChI Identifier |
InChI=1S/C2H7N/c1-3-2/h3H,1-2H3 |
| InChI Key |
ROSDSFDQCJNGOL-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aliphatic Acyclic Compounds |
| Class |
Alkylamines |
| Sub Class |
N/A |
| Other Descriptors |
- methylamines(ChEBI)
- secondary aliphatic amine(ChEBI)
|
| Substituents |
|
| Direct Parent |
Alkylamines |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
|
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Liquid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
-92.2 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
1630 mg/mL at 40 °C |
Not Available |
| LogP |
-0.38 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Saliva
- Urine
|
| Tissue Location |
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
20.18 (3.33-53.22) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
1.43 +/- 0.23 uM |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
3.3 +/- 1.5 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
2.0 +/- 1.0 uM |
Not Specified |
Both |
Normal |
Not Available |
| Saliva |
Detected and Quantified |
|
1-65 uM |
Adult (>18 years old) |
Male |
normal |
At rest without stimulation
|
| Saliva |
Detected and Quantified |
|
1-30 uM |
Adult (>18 years old) |
Male |
normal |
Salivary induction with a citric acid solution...
|
| Saliva |
Detected and Quantified |
|
136 (9.00-262) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
19.2 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
30.8 (20.3-59.2) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
36.13 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
34.4 +/- 9.3 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
39.3 +/- 8.3 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
25.2 +/- 1.2 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
After green tea sonsumption
|
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
After black tea sonsumption
|
| Urine |
Detected and Quantified |
|
30.35 (16.30 – 50.36) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
25.0 (22.0-28.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
29.1 +/- 12.1 uM |
Adult (>18 years old) |
Both |
Kidney disease |
chronic renal failure with continuous...
|
| Urine |
Detected and Quantified |
|
25.4 (8.22-42.7) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Diabetes |
Diabetes mellitus with ketoacidosis
|
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Autosomal dominant polycystic kidney disease |
Not Available |
| Urine |
Detected and Quantified |
|
52 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Rhabdomyolysis |
Not Available |
| Urine |
Detected and Quantified |
|
35.268 (6.543 - 159.703) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Bladder infections |
Chronic bacterial infections of the urinary...
|
| Urine |
Detected and Quantified |
|
32.42 (4.89 – 61.25) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Type 1 diabetes Mellitus |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Diabetes mellitus type 2 |
- Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.
Pubmed: 7758205
|
| Rhabdomyolysis |
- Bairaktari E, Seferiadis K, Liamis G, Psihogios N, Tsolas O, Elisaf M: Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine. Clin Chem. 2002 Jul;48(7):1106-9.
Pubmed: 12089184
|
| Kidney disease |
- Teerlink T, Hennekes MW, Mulder C, Brulez HF: Determination of dimethylamine in biological samples by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997 Apr 11;691(2):269-76.
Pubmed: 9174262
|
|
| Associated OMIM IDs |
- 125853
(Diabetes mellitus type 2)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB012589 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
654  |
| KEGG Compound ID |
C00543  |
| BioCyc ID |
DIMETHYLAMINE  |
| BiGG ID |
Not Available |
| Wikipedia Link |
Dimethylamine  |
| NuGOwiki Link |
HMDB00087  |
| Metagene Link |
HMDB00087  |
| METLIN ID |
3758  |
| PubChem Compound |
674  |
| PDB ID |
DMN  |
| ChEBI ID |
17170  |
| References |
| Synthesis Reference |
Zones, Stacey I.; Burton, Allen W. Production of methylamine and dimethylamine using STI zeolite catalysts. U.S. Pat. Appl. Publ. (2007), 6pp. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7.
Pubmed: 12097436
- Zeisel SH, daCosta KA, Youssef M, Hensey S: Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship. J Nutr. 1989 May;119(5):800-4.
Pubmed: 2723829
- Lee L, Archer MC, Bruce WR: Absence of volatile nitrosamines in human feces. Cancer Res. 1981 Oct;41(10):3992-4.
Pubmed: 7285009
- Sharif NA, Crider JY, Davis TL: AL-3138 antagonizes FP prostanoid receptor-mediated inositol phosphates generation: comparison with some purported FP antagonists. J Pharm Pharmacol. 2000 Dec;52(12):1529-39.
Pubmed: 11197083
- Hughes R, Dart J, Kilvington S: Activity of the amidoamine myristamidopropyl dimethylamine against keratitis pathogens. J Antimicrob Chemother. 2003 Jun;51(6):1415-8. Epub 2003 Apr 25.
Pubmed: 12716783
- Le Moyec L, Racine S, Le Toumelin P, Adnet F, Larue V, Cohen Y, Leroux Y, Cupa M, Hantz E: Aminoglycoside and glycopeptide renal toxicity in intensive care patients studied by proton magnetic resonance spectroscopy of urine. Crit Care Med. 2002 Jun;30(6):1242-5.
Pubmed: 12072675
- Lee SH, Kim SO, Chung BC: Gas chromatographic-mass spectrometric determination of urinary oxoacids using O-(2,3,4,5,6-pentafluorobenzyl)oxime-trimethylsilyl ester derivatization and cation-exchange chromatography. J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):1-7.
Pubmed: 9869358
- Mulder C, Wahlund LO, Blomberg M, de Jong S, van Kamp GJ, Scheltens P, Teerlink T: Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid. J Neural Transm. 2002 Sep;109(9):1203-8.
Pubmed: 12203047
- Sweatman BC, Farrant RD, Holmes E, Ghauri FY, Nicholson JK, Lindon JC: 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal. 1993 Aug;11(8):651-64.
Pubmed: 8257730
- Messana I, Forni F, Ferrari F, Rossi C, Giardina B, Zuppi C: Proton nuclear magnetic resonance spectral profiles of urine in type II diabetic patients. Clin Chem. 1998 Jul;44(7):1529-34.
Pubmed: 9665433
- Nicholson JK, Foxall PJ, Spraul M, Farrant RD, Lindon JC: 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal Chem. 1995 Mar 1;67(5):793-811.
Pubmed: 7762816
- Lichtenberger LM, Gardner JW, Barreto JC, Morriss FH Jr: Evidence for a role of volatile amines in the development of neonatal hypergastrinemia. J Pediatr Gastroenterol Nutr. 1991 Nov;13(4):342-6.
Pubmed: 1779307
- Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.
Pubmed: 7758205
- Choi SY, Chung MJ, Sung NJ: Volatile N-nitrosamine inhibition after intake Korean green tea and Maesil (Prunus mume SIEB. et ZACC.) extracts with an amine-rich diet in subjects ingesting nitrate. Food Chem Toxicol. 2002 Jul;40(7):949-57.
Pubmed: 12065217
- Kilvington S, Hughes R, Byas J, Dart J: Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates. Antimicrob Agents Chemother. 2002 Jun;46(6):2007-9.
Pubmed: 12019127
|